Evidence map›Paper›PMID 33871353›Full record

ArticleeLife2021

Genetic determinants facilitating the evolution of resistance to carbapenem antibiotics.

Peijun Ma, Lorrie L He, Alejandro Pironti, Hannah H Laibinis, Christoph M Ernst, Abigail L Manson, Roby P Bhattacharyya, Ashlee M Earl, Jonathan Livny, Deborah T Hung

Open access · goldAbstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. A posttranslational modification of fimbriae drives pathogenicity inProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Role of Mobilome in Carbapenem Resistance.Antibiotics (Basel, Switzerland) · 2026
    Review
  8. Article
  9. Article
  10. The oral penems and carbapenems.Clinical microbiology reviews · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Proteogenomic analysis demonstrates increasedAntimicrobial agents and chemotherapy · 2025
    Article
  15. ESBL-ProducingMicroorganisms · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Diverse Role ofAntibiotics (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Peijun MaThe Broad Institute of MIT and Harvard, Cambridge, United States.ORCID 0000-0002-7670-7016
Lorrie L HeThe Broad Institute of MIT and Harvard, Cambridge, United States.
Alejandro PirontiThe Broad Institute of MIT and Harvard, Cambridge, United States.ORCID 0000-0002-7759-6776
Hannah H LaibinisThe Broad Institute of MIT and Harvard, Cambridge, United States.
Christoph M ErnstThe Broad Institute of MIT and Harvard, Cambridge, United States.ORCID 0000-0002-5575-1325
Abigail L MansonThe Broad Institute of MIT and Harvard, Cambridge, United States.ORCID 0000-0002-3800-0714
Roby P BhattacharyyaThe Broad Institute of MIT and Harvard, Cambridge, United States.ORCID 0000-0001-6955-5088
Ashlee M EarlThe Broad Institute of MIT and Harvard, Cambridge, United States.ORCID 0000-0001-7857-9145
Jonathan LivnyThe Broad Institute of MIT and Harvard, Cambridge, United States.
Deborah T HungThe Broad Institute of MIT and Harvard, Cambridge, United States.ORCID 0000-0003-4262-0673
Broad Institute · US

Funding

Viral Genomics: evolution, spread, and host interactionsU19AI110818 · NIAID · BROAD INSTITUTE, INC. · PI NEAFSEY, DANIEL E · 2014 to 2024
$66.5M
RNA based diagnostics for rapid pathogen identification and drug resistanceR01AI117043 · NIAID · BROAD INSTITUTE, INC. · PI HUNG, DEBORAH T · 2015 to 2019
$6.5M
NIAID NIH HHS R01 AI117043NIAID NIH HHS U19 AI110818
6 · The paper itself

Abstract

In this era of rising antibiotic resistance, in contrast to our increasing understanding of mechanisms that cause resistance, our understanding of mechanisms that influence the propensity to evolve resistance remains limited. Here, we identified genetic factors that facilitate the evolution of resistance to carbapenems, the antibiotic of 'last resort', in

Indexed as

Evolution, MolecularAnti-Bacterial AgentsCarbapenemsDrug Resistance, BacterialKlebsiella pneumoniaeAnti-Bacterial AgentsCarbapenemsantibioticscarbapenemevolutionevolutionary biologyinfectious diseaseklebsiellamicrobiologyresistance

Identifiers

PMID33871353
PMCPMC8079144
OpenAlexW3153688474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.